HomeNewsBusinessMylab to make 1 crore COVID home test kits before national rollout on June 1

Mylab to make 1 crore COVID home test kits before national rollout on June 1

Mylab Chief Executive Officer Rahul Patil told Reuters that the company had received interest from government agencies and companies for its test kits. "Any individual without any technical expertise can perform the test. And our objective is to make sure it reaches villages as well," Patil said.

May 24, 2021 / 10:40 IST
Story continues below Advertisement
Globally, more than 16.21 crore people have been infected by the coronavirus and 33.64 lakh have died so far. (Representative image)
Globally, more than 16.21 crore people have been infected by the coronavirus and 33.64 lakh have died so far. (Representative image)

Mylab Discovery Solutions has the capacity to ramp up production of its at-home COVID-19 test kits to 100 million units per week over the next few months based on demand, the Indian diagnostics company told Reuters.

Story continues below Advertisement

Mylab Chief Executive Officer Rahul Patil told Reuters that the company had received interest from government agencies and companies for its test kits. "Any individual without any technical expertise can perform the test. And our objective is to make sure it reaches villages as well," Patil said.

Although at-home tests are widely used outside of India, the authorisation of Mylab's kit earlier this week marked the first such approval in the country, which is in the grip of a fierce second wave of the pandemic that is starting to take a huge toll on its vast rural population.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show